Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. 2000 Jan. 30(1):54-60. [QxMD MEDLINE Link].
Simakachorn N, Pichaipat V, Rithipornpaisarn P, et al. Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J Pediatr Gastroenterol Nutr. 2000 Jan. 30(1):68-72. [QxMD MEDLINE Link].
Duggan C, Nurko S. "Feeding the gut": the scientific basis for continued enteral nutrition during acute diarrhea. J Pediatr. 1997 Dec. 131(6):801-8. [QxMD MEDLINE Link].
Salminen S, Isolauri E, Onnela T. Gut flora in normal and disordered states. Chemotherapy. 1995. 41 suppl 1:5-15. [QxMD MEDLINE Link].
Marks MI. Infectious diarrhea: introduction and commentary. Pediatr Ann. 1994 Oct. 23(10):526-7. [QxMD MEDLINE Link].
Liebelt EL. Clinical and laboratory evaluation and management of children with vomiting, diarrhea, and dehydration. Curr Opin Pediatr. 1998 Oct. 10(5):461-9. [QxMD MEDLINE Link].
Hamer DH, Gorbach SL. Infectious diarrhea and bacterial food poisoning. Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisinger and Fordtran’s Gastrointestinaland Liver Disease. 6th ed. Philadelphia, Pa: WB Saunders; 1998. 1594-1632.
Xu F, Gonzalez-Escalona N, Haendiges J, et al. Vibrio parahaemolyticus sequence type 631, an emerging foodborne pathogen in North America. J Clin Microbiol. 2016 Dec 14. [QxMD MEDLINE Link].
Cadle RM, Mansouri MD, Logan N, Kudva DR, Musher DM. Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm. 2007 Nov 15. 64(22):2359-63. [QxMD MEDLINE Link].
Wei L, Ratnayake L, Phillips G, et al. Acid suppression medications and bacterial gastroenteritis: a population-based cohort study. Br J Clin Pharmacol. 2017 Jan 5. 27 (1):40-51. [QxMD MEDLINE Link].
Steffen R, Collard F, Tornieporth N, et al. Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica. JAMA. 1999 Mar 3. 281(9):811-7. [QxMD MEDLINE Link]. [Full Text].
Streit JM, Jones RN, Toleman MA, Stratchounski LS, Fritsche TR. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003). Int J Antimicrob Agents. 2006 May. 27(5):367-75. [QxMD MEDLINE Link].
Vital Signs: Preventing Clostridium difficile Infections. MMWR Morb Mortal Wkly Rep. 2012 Mar 9. 61:157-62. [QxMD MEDLINE Link].
World Health Organization. Cholera: fact sheet no. 107. November 2008. Available at http://www.who.int/mediacentre/factsheets/fs107/en/. Accessed: February 19, 2009.
May FJ, Polkinghorne BG, Fearnley EJ. Epidemiology of bacterial toxin-mediated foodborne gastroenteritis outbreaks in Australia, 2001 to 2013. Commun Dis Intell Q Rep. 2016 Dec 24. 40 (4):E460-E469. [QxMD MEDLINE Link].
Lee LA, Gerber AR, Lonsway DR, et al. Yersinia enterocolitica O:3 infections in infants and children, associated with the household preparation of chitterlings. N Engl J Med. 1990 Apr 5. 322(14):984-7. [QxMD MEDLINE Link].
Centers for Disease Control and Prevention. Yersinia enterocolitica. October 25, 2005. Available at http://www.cdc.gov/ncidod/dbmd/diseaseinfo/yersinia_g.htm. Accessed: February 18, 2009.
Centers for Disease Control and Prevention (CDC). Deaths from gastroenteritis double. Available at http://www.cdc.gov/media/releases/2012/p0314_gastroenteritis.html.
Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology. 2006 May. 130(6):1588-94. [QxMD MEDLINE Link].
Calbo E, Freixas N, Xercavins M, et al. Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control. Clin Infect Dis. 2011 Mar. 52(6):743-9. [QxMD MEDLINE Link].
Biswas JS, Al-Ali A, Rajput P, Smith D, Goldenberg SD. A parallel diagnostic accuracy study of three molecular panels for the detection of bacterial gastroenteritis. Eur J Clin Microbiol Infect Dis. 2014 Nov. 33 (11):2075-81. [QxMD MEDLINE Link].
Humphries RM, Linscott AJ. Laboratory diagnosis of bacterial gastroenteritis. Clin Microbiol Rev. 2015 Jan. 28 (1):3-31. [QxMD MEDLINE Link].
Cody SH, Abbott SL, Marfin AA, et al. Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northern California. JAMA. 1999 May 19. 281(19):1805-10. [QxMD MEDLINE Link]. [Full Text].
World Health Organization. Drug-resistant Salmonella: fact sheet no. 139. Revised April 2005. Available at http://www.who.int/mediacentre/factsheets/fs139/en/. Accessed: February 19, 2009.
Guandalini S, Dincer AP. Nutritional management in diarrhoeal disease. Baillieres Clin Gastroenterol. 1998 Dec. 12(4):697-717. [QxMD MEDLINE Link].
Sullivan PB. Nutritional management of acute diarrhea. Nutrition. 1998 Oct. 14(10):758-62. [QxMD MEDLINE Link].
Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al, for the Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006 Jan 5. 354(1):11-22. [QxMD MEDLINE Link]. [Full Text].
Brooks M. FDA clears novel test for infectious gastroenteritis. Medscape Medical News. January 15, 2013. Available at http://www.medscape.com/viewarticle/777671. Accessed: February 9, 2013.
DuPont HL, The Practice Parameters Committee of the American College of Gastroenterology. Guidelines on acute infectious diarrhea in adults. Am J Gastroenterol. 1997 Nov. 92(11):1962-75. [QxMD MEDLINE Link].
Garcia Rodriguez LA, Ruigomez A, Panes J. Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clin Gastroenterol Hepatol. 2007 Dec. 5(12):1418-23. [QxMD MEDLINE Link].
Gibreel A, Taylor DE. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother. 2006 Aug. 58(2):243-55. [QxMD MEDLINE Link]. [Full Text].
Kaur S, Vaishnavi C, Prasad KK, Ray P, Kochhar R. Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice. Microbiol Immunol. 2007. 51(12):1209-14. [QxMD MEDLINE Link]. [Full Text].
Mines D, Stahmer S, Shepherd SM. Poisonings: food, fish, shellfish. Emerg Med Clin North Am. 1997 Feb. 15(1):157-77. [QxMD MEDLINE Link].
Nataro JP, Steiner T, Guerrant RL. Enteroaggregative Escherichia coli. Emerg Infect Dis. 1998 Apr-Jun. 4(2):251-61. [QxMD MEDLINE Link].
Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Med. 2006 Jun. 119(6 suppl 1):S20-8; discussion S62-70. [QxMD MEDLINE Link].
Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ. 1999 Feb 27. 318(7183):565-6. [QxMD MEDLINE Link]. [Full Text].
Trachtman H, Christen E. Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome. Curr Opin Pediatr. 1999 Apr. 11(2):162-8. [QxMD MEDLINE Link].
Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000 Jun 29. 342(26):1930-6. [QxMD MEDLINE Link]. [Full Text].
Campylobacter (Campylobacteriosis). Centers for Disease Control and Prevention (CDC). Available at https://www.cdc.gov/campylobacter/technical.html. Accessed: February 15, 2018.
Cuypers WL, Jacobs J, Wong V, Klemm EJ, Deborggraeve S, Van Puyvelde S. Fluoroquinolone resistance in Salmonella: insights by whole-genome sequencing. Microb Genom. 2018 Jul 5. [QxMD MEDLINE Link].
US Food and Drug Administration. FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions. Available at https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm612995.htm. July 10, 2018; Accessed: July 18, 2018.
Frellick M. FDA: Stronger fluoroquinolone warnings for mental health, hypoglycemia. Available at https://www.medscape.com/viewarticle/899142. July 10, 2018; Accessed: July 18, 2018.
Mylius M, Dreesman J, Pulz M, et al. Shiga toxin-producing Escherichia coli O103:H2 outbreak in Germany after school trip to Austria due to raw cow milk, 2017 - The important role of international collaboration for outbreak investigations. Int J Med Microbiol. 2018 Jul. 308 (5):539-44. [QxMD MEDLINE Link].
Calderaro A, Martinelli M, Buttrini M, et al. Contribution of the FilmArray(R) Gastrointestinal Panel in the laboratory diagnosis of gastroenteritis in a cohort of children: a two-year prospective study. Int J Med Microbiol. 2018 Jul. 308 (5):514-21. [QxMD MEDLINE Link].
Goldenberg JZ, Yap C, Lytvyn L, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017 Dec 19. 12:CD006095. [QxMD MEDLINE Link].
Surana NK, Kasper DL. Moving beyond microbiome-wide associations to causal microbe identification. Nature. 2017 Dec 14. 552 (7684):244-7. [QxMD MEDLINE Link].
[Guideline] Berenger B, Chui L, Reimer AR, et al, for the Canadian Public Health Laboratory Network. Canadian Public Health Laboratory Network position statement: Non-culture based diagnostics for gastroenteritis and implications for public health investigations. Can Commun Dis Rep. 2017 Dec 7. 43 (12):279-81. [QxMD MEDLINE Link].
Lee H, Ku HJ, Lee DH, et al. Characterization and genomic study of the novel bacteriophage HY01 infecting both Escherichia coli O157:H7 and Shigella flexneri: potential as a biocontrol agent in food. PLoS One. 2016. 11 (12):e0168985. [QxMD MEDLINE Link].
Chen Y, Liu B, Glass K, Du W, Banks E, Kirk M. Use of proton pump inhibitors and the risk of hospitalization for infectious gastroenteritis. PLoS One. 2016. 11 (12):e0168618. [QxMD MEDLINE Link].